Beschrijving

To progress with Phase 3b project as per agreement with EDCTP (WP1, WP3, WP4). To evaluate the peripheral parasitological clearance rate of P.falciparum malaria at day 42 in non-pregnant adults with malaria, taking either NVP-based or EFV-based antiretroviral drugs after administration of any of the three ACTs (AL, AS-AQ, DHA-PIPQ).

AcroniemADAPT
StatusVoltooid
Effectieve start/einddatum14/07/0913/07/13

Financiering

  • European & Developing Countries Clinical Trials Partnership : 304.139,00 €

ID: 1081590